Clinical Trial Update: Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life

View source ↗

Summary

Clinical trial evaluating how switching cystic fibrosis patients from inhaled to tobramycin inhaler affects adherence and quality of life; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Solution (tobramycin inhalation solution)
• Tobramycin inhaler (tobramycin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Alteration in Quality of Life of CF Patients, Following Change of Treatment From Antibiotic Inhalation to Antibiotic Inhaler | Status: UNKNOWN